BMRN
Price
$63.30
Change
+$0.56 (+0.89%)
Updated
Apr 25, 04:59 PM (EDT)
Capitalization
12.03B
6 days until earnings call
SRPT
Price
$60.47
Change
-$1.29 (-2.09%)
Updated
Apr 25, 04:59 PM (EDT)
Capitalization
5.99B
5 days until earnings call
Ad is loading...

BMRN vs SRPT

Header iconBMRN vs SRPT Comparison
Open Charts BMRN vs SRPTBanner chart's image
BioMarin Pharmaceutical
Price$63.30
Change+$0.56 (+0.89%)
Volume$8.98K
Capitalization12.03B
Sarepta Therapeutics
Price$60.47
Change-$1.29 (-2.09%)
Volume$18.97K
Capitalization5.99B
BMRN vs SRPT Comparison Chart
Loading...
BMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BMRN vs. SRPT commentary
Apr 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMRN is a StrongBuy and SRPT is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 26, 2025
Stock price -- (BMRN: $62.74 vs. SRPT: $61.76)
Brand notoriety: BMRN: Not notable vs. SRPT: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BMRN: 51% vs. SRPT: 68%
Market capitalization -- BMRN: $12.03B vs. SRPT: $5.99B
BMRN [@Biotechnology] is valued at $12.03B. SRPT’s [@Biotechnology] market capitalization is $5.99B. The market cap for tickers in the [@Biotechnology] industry ranges from $275.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.16B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMRN’s FA Score shows that 0 FA rating(s) are green whileSRPT’s FA Score has 0 green FA rating(s).

  • BMRN’s FA Score: 0 green, 5 red.
  • SRPT’s FA Score: 0 green, 5 red.
According to our system of comparison, SRPT is a better buy in the long-term than BMRN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMRN’s TA Score shows that 5 TA indicator(s) are bullish while SRPT’s TA Score has 4 bullish TA indicator(s).

  • BMRN’s TA Score: 5 bullish, 5 bearish.
  • SRPT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both BMRN and SRPT are a good buy in the short-term.

Price Growth

BMRN (@Biotechnology) experienced а +6.03% price change this week, while SRPT (@Biotechnology) price change was +14.82% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.20%. For the same industry, the average monthly price growth was -4.19%, and the average quarterly price growth was -12.04%.

Reported Earning Dates

BMRN is expected to report earnings on Aug 05, 2025.

SRPT is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (+7.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BMRN($12B) has a higher market cap than SRPT($5.99B). BMRN has higher P/E ratio than SRPT: BMRN (28.39) vs SRPT (26.39). BMRN YTD gains are higher at: -4.549 vs. SRPT (-49.206). BMRN has higher annual earnings (EBITDA): 651M vs. SRPT (317M). SRPT has more cash in the bank: 1.36B vs. BMRN (1.14B). BMRN has less debt than SRPT: BMRN (603M) vs SRPT (1.34B). BMRN has higher revenues than SRPT: BMRN (2.85B) vs SRPT (1.9B).
BMRNSRPTBMRN / SRPT
Capitalization12B5.99B200%
EBITDA651M317M205%
Gain YTD-4.549-49.2069%
P/E Ratio28.3926.39108%
Revenue2.85B1.9B150%
Total Cash1.14B1.36B84%
Total Debt603M1.34B45%
FUNDAMENTALS RATINGS
BMRN vs SRPT: Fundamental Ratings
BMRN
SRPT
OUTLOOK RATING
1..100
133
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
69
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
7746
PRICE GROWTH RATING
1..100
7693
P/E GROWTH RATING
1..100
98100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BMRN's Valuation (68) in the Biotechnology industry is in the same range as SRPT (69). This means that BMRN’s stock grew similarly to SRPT’s over the last 12 months.

BMRN's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as SRPT (100). This means that BMRN’s stock grew similarly to SRPT’s over the last 12 months.

SRPT's SMR Rating (46) in the Biotechnology industry is in the same range as BMRN (77). This means that SRPT’s stock grew similarly to BMRN’s over the last 12 months.

BMRN's Price Growth Rating (76) in the Biotechnology industry is in the same range as SRPT (93). This means that BMRN’s stock grew similarly to SRPT’s over the last 12 months.

BMRN's P/E Growth Rating (98) in the Biotechnology industry is in the same range as SRPT (100). This means that BMRN’s stock grew similarly to SRPT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BMRNSRPT
RSI
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
74%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
65%
Bearish Trend 2 days ago
80%
Momentum
ODDS (%)
Bullish Trend 2 days ago
64%
Bullish Trend 2 days ago
73%
MACD
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
68%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
57%
Bullish Trend 2 days ago
73%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
62%
Bearish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 2 days ago
61%
Bullish Trend 2 days ago
74%
Declines
ODDS (%)
Bearish Trend 18 days ago
60%
Bearish Trend 9 days ago
77%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
71%
Aroon
ODDS (%)
Bearish Trend 2 days ago
56%
Bearish Trend 2 days ago
78%
View a ticker or compare two or three
Ad is loading...
BMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
HFGO21.441.08
+5.30%
Hartford Large Cap Growth ETF
VIG188.352.52
+1.36%
Vanguard Dividend Appreciation ETF
RFMZ12.520.12
+0.97%
RiverNorth Flexible Municipal Income Fund II
EVV9.770.07
+0.72%
Eaton Vance Limited
USML39.13N/A
N/A
ETRACS 2x Lvrgd MSCI US Mn Vl Fct TR ETN

BMRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, BMRN has been loosely correlated with IBO. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if BMRN jumps, then IBO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMRN
1D Price
Change %
BMRN100%
+1.29%
IBO - BMRN
45%
Loosely correlated
-0.19%
SRPT - BMRN
45%
Loosely correlated
+3.82%
IONS - BMRN
42%
Loosely correlated
+1.62%
ITOS - BMRN
42%
Loosely correlated
+4.34%
AXON - BMRN
42%
Loosely correlated
+2.39%
More

SRPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, SRPT has been loosely correlated with GLMD. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if SRPT jumps, then GLMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRPT
1D Price
Change %
SRPT100%
+3.82%
GLMD - SRPT
51%
Loosely correlated
-0.61%
ALZN - SRPT
49%
Loosely correlated
+2.26%
TECX - SRPT
46%
Loosely correlated
+14.53%
INSM - SRPT
44%
Loosely correlated
-2.60%
AXON - SRPT
43%
Loosely correlated
+2.39%
More